BioSpace News Archive

Decontamination is a process of deep cleansing to remove any kind of contamination such as micro-organisms and hazardous elements such as radioactive substances, infectious diseases, and chemicals.

There is little contention about the importance of asthma spacers for people suffering from various degrees of the pulmonary disease.

A quality-based program is vital in every compounding pharmacy to ensure that each preparation is compounded properly and is stable for its expected duration of use.

IRISYS LLC, a pharmaceutical contract development and manufacturing company (CDMO), provides contract development and GMP manufacturing services to BioCorRx Pharmaceuticals, Inc., for a sterile naltrexone sub-cutaneous implant, also known as BICX102, which is meant to help in the treatment of opioid use disorder (OUD) and the prevention of

Shineco, Inc. (“Shineco” or the “Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, as well as various health and well-being-focused plant-based products in China, announced today that the Company has entered into a non-binding letter of intent (the “Letter of Intent”) to acquire controlling interest in Changzhou Biowin Pharmaceutical Co., Ltd (“CBP”), a Chinese biotechnology compan

Heritage Global Inc. (OTCQB: HGBL, CSE: HGP) (“Heritage Global,” “HGI” or “the Company”), an asset services company specializing in financial and capital assets, today announced results from its ongoing monthly Pharmaceutical Sector Sale for July.

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that its partner, Austrianova, has submitted a Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA). The DMF provides all confidential and detailed information covering the production

Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for chlorzoxazone tablet, 375 mg, 500 mg and 750 mg, in the United States . Mayne Pharma has commenced commercial launch activities to customers in the US.

Inhibikase Therapeutics, Inc. (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics for Parkinson’s Disease and related disorders that arise inside and outside of the brain, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the pro

Vave Health, a maker of innovative handheld ultrasound technology, today announced Dr. Renee Dversdal as its chief medical officer.